CANBERA (dpa-AFX) - CSL Ltd. (CMXHF.PK, CSL.AX, CSLLY) Tuesday said that its underlying net profit after tax or NPAT, was $2.8 billion in fiscal 2026, down 3 percent from a year ago. On a reported basis, net loss after tax came in at $2.6 billion during the year.
The Australian biotechnology company's underlying net profit after tax before amortisation was $3.1 billion in the given year, down 2 percent. CSL said that group revenue fell 1.0 percent to $15.8 billion in fiscal 2026.
Looking ahead, in fiscal 2027, the company said that group revenue is expected to be broadly in line with fiscal 2026, while underlying NPAT is forecast to increase by approximately 5 percent on a constant-currency basis.
On the ASX, CSL.AX ended Monday's trading at A$196.78, up $1.64 or 0.84 percent.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
